v3.26.1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Collaboration revenue $ 1,248 $ 4,127
Operating expenses:    
Research and development 19,300 25,142
General and administrative 6,535 6,805
Total operating expenses 25,835 31,947
Loss from operations (24,587) (27,820)
Other income (expense):    
Interest income 1,539 2,887
Other expense, net (1) (8)
Total other income, net 1,538 2,879
Net loss before provision for income taxes (23,049) (24,941)
Provision for income taxes (10) (98)
Net loss (23,059) (25,039)
Other comprehensive income (loss):    
Unrealized loss on available-for-sale marketable securities (304) (88)
Comprehensive loss $ (23,363) $ (25,127)
Net loss per share attributable to common stockholders - basic $ (0.61) $ (0.68)
Net loss per share attributable to common stockholders - diluted $ (0.61) $ (0.68)
Weighted-average common shares outstanding - basic 37,581,094 37,019,027
Weighted-average common shares outstanding - diluted 37,581,094 37,019,027